Automated Slide Scanning and Segmentation in Fluorescently-labeled Tissues Using a Widefield High-content Analysis System
May 3rd, 2018
8.8K views
Here we describe a protocol for the automated segmentation of fluorescently labeled tissues on slides using a widefield high-content analysis system (WHCAS). This protocol has wide-ranging applications in any field which involves the quantitation of fluorescent markers in biological tissues including the biological sciences, medical engineering, and health sciences.
Overview
This article presents a protocol for the automated segmentation of fluorescently labeled tissues using a widefield high-content analysis system (WHCAS). This method streamlines the quantification of fluorescent markers in biological tissues, benefiting various fields including biological sciences and medical engineering.
Key Study Components
Area of Science
- Biological Sciences
- Medical Engineering
- Health Sciences
Background
- Automated segmentation enhances the analysis of fluorescently labeled tissues.
- High-content analysis systems facilitate detailed imaging of biological samples.
- Quantification of proteins in tissue samples is crucial for understanding biological processes.
- This method was developed to address challenges in quantifying new cells in brain tissue.
Purpose of Study
- To create an efficient workflow for automatic segmentation of tissue samples.
- To improve the accuracy and speed of quantifying fluorescent markers.
- To provide a standardized protocol applicable to various tissue types.
Methods Used
- Setup of a widefield high-content analysis system for imaging.
- Configuration of experimental settings for optimal imaging.
- Use of software tools for image acquisition and analysis.
- Implementation of autofocus and image-based focusing techniques.
Main Results
- Successful segmentation of fluorescently labeled tissues was achieved.
- High magnification imaging provided detailed views of tissue samples.
- Regions of interest were accurately identified and analyzed.
- Exclusion criteria for out-of-focus or compromised images were established.
Conclusions
- The automated segmentation protocol significantly reduces analysis time.
- This method can be applied to a wide range of biological tissues.
- Future applications may enhance research in various scientific fields.
Frequently Asked Questions
What is the main advantage of using WHCAS?
WHCAS allows for automated and efficient segmentation of fluorescently labeled tissues, saving time and improving accuracy.
Can this method be applied to different types of tissues?
Yes, the protocol is versatile and can be adapted for various biological tissues.
What are the key steps in setting up the imaging system?
Key steps include configuring magnification, camera settings, and ensuring proper wavelength selection.
How does this method improve quantification of proteins?
It provides a standardized approach that enhances accuracy and reduces variability in measurements.
What should be done if images are out of focus?
Use the autofocus feature or manually adjust the step size to achieve focus before capturing images.
Are there any exclusion criteria for image analysis?
Yes, images that are out of focus or contain artifacts like bubbles or folds should be excluded from analysis.
Executive Industry Relevance
Automated slide scanning and segmentation using a widefield high-content analysis system (WHCAS) addresses the bottleneck in quantifying fluorescent markers across large tissue sections, enabling reproducible, high-throughput analysis for target validation and assay development. By standardizing image acquisition and segmentation workflows, this method reduces variability and accelerates preclinical evaluation of tissue-based biomarkers, supporting data-driven go/no-go decisions in early discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying protein expression patterns in disease-relevant tissues.
- Operational Value: Reduces time spent optimizing protocols for individual experiments, allowing rapid application across multiple fluorescently-labeled targets.
- Predictive Value: Supports mechanistic de-risking through consistent, quantitative readouts of marker localization and expression levels.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by generating standardized, segmented tissue images suitable for high-content assays.
- Operational Value: Enhances assay standardization and reproducibility through automated region selection and exclusion of compromised sites (e.g., out-of-focus, folded, or bubbled tissue).
- Scalability: Enables platform reuse across diverse markers and tissue types via pre-built software modules for protein localization, proliferation, viability, apoptosis, and angiogenesis.
Translational & Preclinical Research
- Translational Continuity: Maintains consistency from discovery through preclinical validation by providing quantitative data on marker-positive cell proportions, mean stained area, and fluorescence intensity.
- Risk-Adjusted Advancement: Supports preclinical decision-making by delivering reliable, exclusion-filtered datasets that reflect true biological signal.
- Disease-Relevant System: Demonstrated applicability in brain tumor tissue analysis, with extensibility to any fluorescently-labeled nuclear or cytoplasmic marker in slide-mounted tissues.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from Early Discovery through Lead Identification to Preclinical Research, enabling standardized tissue analysis at each stage.
- Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying marker expression in specific tissue regions of interest.
- Screening: Delivers assay readiness through automated segmentation and quantitative outputs that allow reliable compound evaluation across sites.
- Analytics: Generates measurable readouts including proportion of positive cells, mean stained area, and mean fluorescence intensity, enabling cross-condition comparison.
- Translational Research: Connects to preclinical continuity by providing biomarker-aligned, quantitative tissue data suitable for validation studies.
- Enterprise Reuse: Functions as a reusable capability across projects, leveraging pre-built software modules and saved settings (Setting A and B) for consistent slide scanning and segmentation.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in tissue-based assays.
- Operational Value: Standardization, reproducibility, and scalability of tissue imaging and analysis workflows.
- Strategic Value: Improved go/no-go decisions, capital efficiency via reduced protocol optimization time, and lower late-stage biological risk.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantitative, exclusion-validated tissue data.
Implementation Considerations
- Requires expertise in widefield high-content analysis system operation and associated software navigation.
- Dependent on instrumentation capable of slide scanning, multi-wavelength acquisition, and laser- and image-based focusing.
- Necessitates cross-team standardization of acquisition settings (e.g., magnification, binning, gain) and region-of-interest definition protocols.
- Involves adaptation considerations when applying the method to different tissue types, marker expressions, or slide thicknesses.
- Includes practical limitations such as the need to manually exclude sites with artifacts (e.g., out-of-focus images, tissue folds, bubbles) despite automated acquisition.
Biopharma FAQs
Why does quantitative dependent variable measurement matter for target validation?
Quantitative measurements such as proportion of cells staining positive, mean stained area, and mean fluorescence intensity enable objective assessment of target expression levels, supporting mechanistic de-risking and hypothesis-driven target selection in early discovery.
How does independent variable isolation fit into the discovery pipeline?
Isolating variables like magnification, wavelength, and acquisition settings (Saved as Setting A and B) ensures reproducible imaging conditions, which is essential for reliable target validation and assay standardization across experiments.
What do quantitative dependent variable measurements enable in assay development?
Quantitative outputs from segmentation—such as marker-positive cell ratios and fluorescence intensity—provide the numerical foundation for developing and optimizing high-content assays used in screening and lead identification.
Why do replication requirements matter for cross-functional collaboration?
Replication through standardized slide scanning protocols and exclusion criteria (e.g., removing out-of-focus or artifact-containing sites) ensures data consistency, enabling seamless handoff between discovery, assay development, and preclinical teams.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to analyze segmentation-derived data including proportions, means, and intensity metrics, which support comparative statistical analysis across treatment groups or tissue regions to inform go/no-go decisions.
